Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07907783
PHASE2
Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia
Sponsor: Pelage Pharmaceuticals, Inc.
View on ClinicalTrials.gov
Summary
The study is designed to evaluate safety and efficacy of PP405 in adult female participants with androgenetic alopecia
Official title: A Randomized, Multicenter, Double-Blind, Vehicle-Controlled, Phase 2 Study to Assess Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2026-11
Completion Date
2028-03
Last Updated
2026-10-30
Healthy Volunteers
No
Conditions
Interventions
DRUG
PP405 0.05% Topical Gel
Medicated topical gel containing PP405 0.05%
DRUG
Vehicle Topical Gel
Topical gel